A Novel RNA-Binding Protein Signature to Predict Clinical Outcomes and Guide Clinical Therapy in Gastric Cancer

Objective: This study aimed to develop an RNA-binding protein (RBP)-based signature for risk stratification and guiding clinical therapy in gastric cancer. Methods: Based on survival-related RBPs, an RBP-based signature was established by LASSO regression analysis in TCGA dataset. Kaplan–Meier curve...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Zhigang, Jiang, Haitao, Ju, Kun, Liu, Xichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319385/
https://www.ncbi.nlm.nih.gov/pubmed/34336882
http://dx.doi.org/10.3389/fmed.2021.670141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319385/
https://www.ncbi.nlm.nih.gov/pubmed/34336882
http://dx.doi.org/10.3389/fmed.2021.670141

Ejemplares similares